Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Filamon LTD
Seagen Inc.
Eisai Inc.
Eli Lilly and Company
On Target Laboratories, LLC
PMV Pharmaceuticals, Inc
Kivu Bioscience Inc.
NeoImmuneTech
Hoffmann-La Roche
Qilu Pharmaceutical Co., Ltd.
AstraZeneca
BeOne Medicines
Genmab
Tubulis GmbH
Whitehawk Therapeutics, Inc.
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
AstraZeneca
ViroMissile, Inc.
Arcus Biosciences, Inc.
Cancer Research UK
Bristol-Myers Squibb
Genmab
Jazz Pharmaceuticals
Pfizer
Duke University
A2 Biotherapeutics Inc.
AstraZeneca
Arvinas Inc.
Zhejiang University
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
National Institutes of Health Clinical Center (CC)
Clasp Therapeutics, Inc.
BioNTech SE
Eli Lilly and Company
NiKang Therapeutics, Inc.
Verismo Therapeutics
Poseida Therapeutics, Inc.
DualityBio Inc.
MacroGenics
AstraZeneca